The confluence of next-generation sequencing technologies, computational analysis of the data, and the use of targeted therapy in cancer care raises a “perfect storm” for revolutionizing the clinic. Sequencing experts, bioinformaticists, and clinicians agree that the challenges of translating the vast amounts of data from next-generation sequencing into a resource that can be easily and effectively incorporated into clinical and research programs are significant…